We hypothesize that this decrease is due to normalization of the previous stress-induced hemoconcentration and "internal hemodilution" by nitroglycerin.
The natural time course of hemoglobin concentration in patients with acute coronary syndrome (ACS) has not yet been studied. We recently became aware of a decrease in hemoglobin concentration in patients with ACS lacking any sign of evident blood loss. The present observational study evaluates this phenomenon and proposes reference values of hemoglobin decrease for nonbleeding patients with ACS.
Methods and Results
This retrospective descriptive study was performed in an interdisciplinary 8-bed intensive care unit (ICU) of a regional teaching hospital in southern Switzerland. The investigation was approved by the local ethics committee. We screened the charts of all patients admitted to our ICU for ACS ( . Exclusion criteria were active bleeding (e.g., gastrointestinal bleeding), procedures with possible blood loss such as coronary angiography and surgery, transfusion of red blood cells, hemolysis, hemodialysis, and patients with Ͻ2 determinations of hemoglobin. We checked for general patient demographics, total fluid balance (comprehensive of the estimated perspiration), total amount of blood samplings, daily hemoglobin and white blood cells count, cardiac markers of ischemia, and the medication given. We furthermore recorded hemodynamic data and thoracic pain intensity (visual analog scale). The severity of disease was determined by the Simplified Acute Physiology Score II (SAPS II). 1 This scoring system, an analog to Apache II, permits classification of severity of disease and attributes a predicted mortality.
The therapeutic regimen of our patients was adapted to the clinical situation. At arrival they received 250 mg of acetylsalicylic acid intravenously, followed by 100 mg/day by mouth. Clopidogrel was given with a loading dose of 300 mg by mouth, followed by 75 mg/day. Four patients were enrolled in the Electrocardiogram Clarity-Thrombolysis In Myocardiol Infarction (TIMI) 28 study and received the study drug. 2 The dose of unfractioned heparin was tailored to augment the activated partial thromboplastin time value to 1.5 to 2.3 times the control value. Patients treated with low-molecular-weight heparins received nadroparin 2 ϫ 86 IU/kg body weight subcutaneously. Tirofiban and thrombolytic agents were applied according to the body weight, following the recommendations of the manufacturers.
The analysis was retrospective and the sample size was not defined on the basis of power consideration. Continuous data are reported as means Ϯ SDs. We examined the charts of 172 patients with ACS. Sixtynine patients were excluded from final evaluation because of insufficient hemoglobin assessments (n ϭ 48), too short length of stay (n ϭ 8), previous procedures with unknown blood loss (n ϭ 4), preexistent anemia requiring blood transfusions (n ϭ 5), gastric ulcer disease with active bleeding (n ϭ 2), hemolysis (n ϭ 1), and chronic intermittent hemodialysis (n ϭ 1). Thus, the analysis concerned 103 white nonbleeding patients with ACS, 6 of whom with cardiac arrest, who met the inclusion criteria. General patient demographics are listed in Table 1 .
The mean hemoglobin concentration at ICU admission was 13.90 Ϯ 1.62 g/dl and decreased during the ICU stay for 88% of patients. After a decrease of 1.29 Ϯ 0.79 g/dl during the first 12 to 24 hours (95% confidence interval 1.12 to 1.46 g/dl, p Ͻ0.001), it remained stable (mean reduction for the complete ICU stay of 1.27 Ϯ 1.00 g/dl; Figure 1 ). The average fluid balance during the entire ICU stay was Ϫ616 Ϯ 1,465 ml, ϩ 771 ml in the subgroup of patients who died (p Ͻ0.001), and blood samplings accounted for 52 Ϯ 18 ml. We found a positive correlation between the height of the SAPS II score and the global fluid balance (correlation coefficient 0.325, p Ͻ0.001), but there was no evidence of correlation between the fluid balance and the hemoglobin decline (p ϭ 0.150). The decrease in hemoglobin was more important in patients with a higher SAPS II score (ϩ0.02 g/dl per unit of SAPS II, p Ͻ0.001). In contrast, it was less for patients who died during the hospitalization (difference of 0.95 g/dl, p Ͻ0.001).
Data concerning the therapeutic regimen are reported in Table 2 . There was no significant relation between the administration of clopidogrel (p ϭ 0.600) or tirofiban (p ϭ 0.646) and the hemoglobin decrease. In contrast, hemoglobin significantly decreased after systemic thrombolysis (Ϫ0.58 g/dl, p ϭ 0.008). Patients receiving nitrates had a mean hemoglobin decrease of 1.43 g/dl during the first 12 to 24 hours, whereas those not receiving nitrates had a hemoglobin decrease of 0.89 g/dl (p ϭ 0.004). The relation between the administration of ␤ blockers and the degree of hemoglobin decrease did not reach a significant level (p ϭ 0.070). Data concerning hemodynamic parameters, white blood cells, and thoracic pain intensity are reported in Table 3 . There was an association between the hemoglobin course, the decrease of arterial pressure during the ICU stay (0.01 g/dl by decrease of 1 mm Hg, p ϭ 0.019), the decrease in heart rate (0.01 g/dl by decrease of 1 beat/min, p ϭ 0.004), the lessening of pain intensity (0.06 g/dl per unit on the visual analog scale, p ϭ 0.043), and the decrease of white blood cells during the hospitalization (0.06 g/dl by decrease of 10 3 /l, p ϭ 0.021).
Discussion
The present observational study evaluates the time course of blood hemoglobin concentrations in a population of nonbleeding patients with ACS with the additional purpose of providing reference values and evaluating possible affecting factors, considering that these patients are exposed to many drugs that can promote bleeding. Our data indicate that the hemoglobin level decreases 1.29 Ϯ 0.79 g/dl during the first 12 to 24 hours and then remains constant during the remaining stay in the ICU. Theoretically, this might be due to the many blood samples taken at beginning of the hospitalization. As described in the past, blood samplings can contribute to a reduction of hemoglobin concentration, a phenomenon referred to as nosocomial or iatrogenic anemia. 3, 4 However, the total amount of blood needed for laboratory testing has decreased over the years with improvement in techniques and equipment, and in our study it was rather limited, with an average of 52 ml during the entire ICU stay. In relation to the assumed mean weight of our patients 5 this would imply a hemoglobin decrease of 0.13 to 0.15 g/dl (estimated blood volume 7% of body weight), 6 which is far from the value observed in our study. The fluid balance was constant or negative with only 8 exceptions, therefore hemodilution after correction of fluid deficits can be discarded as a reason for the hemoglobin reduction. The mean ICU stay was too short for nutritional, endocrine, renal, or hepatic insufficiency to influence the course of hemoglobin level.
Our statistical analysis could not demonstrate a relation between the number and type of platelet-inhibiting and anticoagulating drugs and the course of hemoglobin concentration. This might be due in part to the limited sample size and the presence of very similar treatment protocols among the patients. The only significant correlation was found between the application of systemic thrombolysis and the degree of hemoglobin decrease, but this is in the absence of a visible blood loss.
About 3/4 of our patients received nitroglycerin intravenously during the first hours of hospitalization. Brugger et al 7 and Arend et al 8 described an effect called internal hemodilution after the administration of nitrates. The latter reported an average hemoglobin decrease after administration of intravenous nitroglycerin for 24 hours of 1.48 g/dl, a value close to our results.
We found a statistical correlation between the amount of hemoglobin decrease, the difference of blood pressure, heart rate, pain acuity, and white blood cells between admission and discharge. As reported by Patterson et al 9 on 29 healthy men, acute psychological stress can produce a significant hemoconcentration, probably through a fluid shift from the Continuous data are presented as mean Ϯ SD.
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The American Journal of Cardiology (www. AJConline.org) vascular to the interstitial space secondary to vasoconstriction. After fading of stress, the fluid backflow from the interstitial space to the vascular bed may explain the decrease in hemoglobin level. Patients with a higher SAPS II score, being more acutely ill at admission, showed more hemoglobin decline, probably due to the same mechanism. The reason why patients who died experienced less hemoglobin decrease, is not completely clear, as their mean positive fluid balance would imply the contrary. On one hand they received less nitrates. On the other, their reduced decrease in hemoglobin level could represent a sign of ongoing instability and stress. Considering the small sample size, these results might also be due to chance.
Patients receiving blood transfusions were excluded from our study. There are few clinical data about the hemoglobin threshold for transfusion in patients with cardiac disease. 10 Most clinical trials were conducted on patients undergoing coronary artery bypass. 11 For elderly patients with acute myocardial infarction, Wu and al 12 reported that blood transfusion was associated with lesser short-term mortality if the hematocrit at admission was Յ30.0% and may still be effective with a hematocrit as high as 33.0% on admission. Based on these data, the hemoglobin threshold for transfusion in patients with ACS is set at most institutions between 8.5 and 10 g/dl.
Our study has several limits. The retrospective observational design implies possible selection bias. For instance, 28% of the screened patients were discarded from the study population because of insufficient hemoglobin assessments. In contrast, the scattered measurement of hemoglobin level could also potentially influence the data. One difficulty with such an analysis is the unavoidable decrease in the number of patients over time, as patients are discharged early, are transferred to other institutions, or die. Although patients discharged or transferred could be followed up for a prede- termined time interval, we did not collect these data considering the bias caused by the different laboratory techniques. Although no occult blood losses were recognized, one cannot entirely exclude unrecognized gastrointestinal bleeding as a contributing factor. 13 However, there are Ն2 arguments that make this hypothesis rather improbable: (1) a hemoglobin decease could be noted in as much as 88% of the examined patients and (2) the rapid onset of hemoglobin decrease with consequently stable values despite continuing the previously described therapy.
